Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels

Peer Review reports

Original Submission
24 Mar 2013	Submitted	Original manuscript
20 May 2013	Reviewed	Reviewer Report - Eva Segelov
11 Jun 2013	Reviewed	Reviewer Report - Niall Tebbutt
30 Aug 2013	Author responded	Author comments - Christophe Borg
Resubmission - Version 2
30 Aug 2013	Submitted	Manuscript version 2
3 Nov 2013	Reviewed	Reviewer Report - Eva Segelov
9 Dec 2013	Author responded	Author comments - Christophe Borg
Resubmission - Version 3
9 Dec 2013	Submitted	Manuscript version 3
Publishing
10 Dec 2013	Editorially accepted
27 Dec 2013	Article published	10.1186/1471-2407-13-611

Back to article page